3,4-Dihydroxybenzylamine: An Improved Dopamine Analog Cytotoxic for Melanoma Cells in Part Through Oxidation Products Inhibitory to DNA Polymerase
Authors:
- George B. FitzGeraldGFGeorge B. FitzGerald
- Michael M. WickMWMichael M. Wick
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 80 (2) , 119-123
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inhibition of reverse transcriptase by tyrosinase generated quinones related to levodopa and dopamineChemico-Biological Interactions, 1981
- Electron spin resonance characterization of radicals from 3,4-dihydroxyphenylalanine: semiquinone anions and their metal chelatesJournal of the American Chemical Society, 1981
- Regulation of ribonucleotide reductase in mammalian cells by chemotherapeutic agentsAdvances in Enzyme Regulation, 1981
- An Experimental Approach to the Chemotherapy of MelanomaJournal of Investigative Dermatology, 1980
- Reduction of RibonucleotidesAnnual Review of Biochemistry, 1979
- L-Dopa methyl ester as a new antitumour agentNature, 1977
- Potential oxidative pathways of brain catecholaminesJournal of Medicinal Chemistry, 1976
- Molecular Order of Participation of Inhibitors (or Activators) in Biological SystemsScience, 1969
- Zur Kenntnis der o‐Chinone, XXVI: Neue Mono‐ und DihydroxynaphthochinoneEuropean Journal of Inorganic Chemistry, 1965
- Identification by electron spin resonance spectroscopy of the primary product of tyrosinase-catalyzed catechol oxidationBiochemical and Biophysical Research Communications, 1961